OCT 02, 2019 8:17 AM PDT

Compound in Daffodils Can Help Fight Cancer

WRITTEN BY: Annie Lennon

Preventing the growth of tumors presents a challenge for scientists in finding a cure to cancer. Now however, researchers from the University Libre de Bruxelles have identified a natural alkaloid in daffodils that may be useful in developing anti-cancer drugs.

To sustain growth and multiply, cancer cells rely on manipulating the body’s ways of synthesizing proteins- something that happens in our cell’s ribosomes. Thus, they tend to be very sensitive to treatments that inhibit the ability of these ribosomes to produce proteins. 

In research led by Denis Lafontaine, scientists found a natural anti-cancer compound, known as haemanthamine, when studying daffodils. Binding to ribosomes, they were observed to slow the growth of cancer cells by blocking their ability to produce proteins. They also found that haemanthamine reduces the production of ribosomes in the cell’s nucleus, which in turn triggers the activation of an anti-tumor surveillance pathway that leads to the stabilization of the protein p53 and the eradication of cancer cells (Libre de Bruxelles: 2018).  

In particular, the activation of the protein p53 is known as an important element in treating cancer due to its role in promoting cell death, also known as apoptosis. This comes as, under normal circumstances, cancer cells generally do not undergo this process, instead growing rapidly and overriding signals that would otherwise lead them to undergo cell death. 

Thus, in avoiding this process, they may then propagate further, both forming into tumors and  spreading to the rest of the body in a process known as metastasis. In stabilizing protein p53 and allowing these cancer cells to undergo cell death, this daffodil alkaloid may help prevent this from happening- both preventing the formation of cancerous tumors and the spread of cancer throughout the body (Persaud: 2018). 

Yet, although this process may help in the destruction of cancer cells, by itself, it may still be problematic. This is because non-cancerous cells also require ribosomal synthesis to function and so, although haemanthamine can be effective in killing cancer cells, it may also kill healthy cells too. Thus, rather than launching this alkaloid into clinical trials, the researchers are currently focusing on understanding its structure better, ideally to create a molecule that functions similarly against cancer, only without the negative side effects. 


 

Sources 

 

Libre De Bruxelles, Universite 

Persaud, Nicholas: Princeton.edu

About the Author
  • Annie graduated from University College London and began traveling the world. She is currently a writer with keen interests in genetics, psychology and neuroscience; her current focus on the interplay between these fields to understand how to create meaningful interactions and environments.
You May Also Like
DEC 02, 2019
Drug Discovery & Development
DEC 02, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
FEB 18, 2020
Microbiology
FEB 18, 2020
Newly Found Glycopeptide Antibiotics Kill Bacteria in a New Way
The overuse and misuse of antibiotics and the adaptability of microbes has created a problem that people must solve....
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Why is it so Difficult to Develop a Vaccine for Coronavirus?
As of February 21st, 2,250 have died worldwide from Coronavirus, while 18,862 have recovered and 55,703 are currently infected. Having made top news storie...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
FDA Approves Non-Statin Drug to Lower Cholesterol
The US Food and Drug Administration (FDA) has approved a new drug that lowers cholesterol levels.The drug, known as Nexletol, works differently from existi...
Loading Comments...